First-in-human in-vivo depiction of paraganglioma metabolism by hyperpolarised
Journal
BJR case reports
ISSN: 2055-7159
Titre abrégé: BJR Case Rep
Pays: England
ID NLM: 101684132
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
20
06
2022
revised:
31
07
2023
accepted:
10
08
2023
medline:
6
11
2023
pubmed:
6
11
2023
entrez:
6
11
2023
Statut:
epublish
Résumé
Phaeochromocytomas (PCC) and paragangliomas (PGL), cumulatively referred to as PPGLs, are neuroendocrine tumours arising from neural crest-derived cells in the sympathetic and parasympathetic nervous systems. Predicting future tumour behaviour and the likelihood of metastatic disease remains problematic as genotype-phenotype correlations are limited, the disease has variable penetrance and, to date, no reliable molecular, cellular or histological markers have emerged. Tumour metabolism quantification can be considered as a method to delineating tumour aggressiveness by utilising hyperpolarised
Identifiants
pubmed: 37928705
doi: 10.1259/bjrcr.20220089
pmc: PMC10621573
doi:
Types de publication
Case Reports
Langues
eng
Pagination
20220089Subventions
Organisme : Cancer Research UK
ID : 26854
Pays : United Kingdom
Informations de copyright
© 2023 The Authors. Published by the British Institute of Radiology.
Références
PLoS One. 2013 Sep 04;8(9):e71996
pubmed: 24023724
Cancer Imaging. 2012 May 07;12:153-62
pubmed: 22571874
BJR Case Rep. 2019 May 15;5(3):20190026
pubmed: 31555479
Sci Transl Med. 2013 Aug 14;5(198):198ra108
pubmed: 23946197
Front Endocrinol (Lausanne). 2020 Oct 27;11:587769
pubmed: 33193100
Cell Metab. 2016 May 10;23(5):867-80
pubmed: 27133130
Cell Metab. 2020 Jan 7;31(1):105-114.e3
pubmed: 31564440
NMR Biomed. 2020 Jun;33(6):e4291
pubmed: 32154970
Clin Genet. 2020 Jan;97(1):39-53
pubmed: 30977114